Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 122-129

  Vickers, Kasey C ^a   Castro Chavez, Fernando ^a   Morrisett, Joel D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Calcifying vascular cells; Lyso phosphatidylcholine; Smooth muscle cells; Vascular calcification

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; CALCIUM 45; CALCIUM PHOSPHATE; LYSOPHOSPHATIDYLCHOLINE; TRANSCRIPTION FACTOR RUNX2; COLLAGEN TYPE 1; OSTEOPONTIN; RUNX2 PROTEIN, HUMAN;

AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MORPHOMETRICS; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STAINING; UPREGULATION; VASCULAR SMOOTH MUSCLE; ATHEROSCLEROSIS; BIOSYNTHESIS; BONE DEVELOPMENT; CALCINOSIS; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; PATHOLOGY; PHYSIOLOGY;

ALKALINE PHOSPHATASE; AORTA; ATHEROSCLEROSIS; CALCINOSIS; CELLS, CULTURED; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MUSCLE, SMOOTH, VASCULAR; OSTEOGENESIS; OSTEOPONTIN; PHENOTYPE;

EID: 77954312930     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.005     Document Type: Article

References (30)

1. Doherty T.M., Asotra K., Fitzpatrick L.A., et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci USA 2003, 100:11201-11206.
2. Abedin M., Tintut Y., Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004, 24:1161-1170.
3. Prabhakaran S., Singh R., Zhou X., et al. Presence of calcified carotid plaque predicts vascular events: the Northern Manhattan Study. Atherosclerosis 2007, 195:197-201.
4. Sangiorgi G., Rumberger J.A., Severson A., et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998, 31:126-133.
5. Speer M.Y., Giachelli C.M. Regulation of cardiovascular calcification. Cardiovasc Pathol 2004, 13:63-70.
6. Steitz S.A., Speer M.Y., Curinga G., et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001, 89:1147-1154.
7. Abedin M., Tintut Y., Demer L.L. Mesenchymal stem cells and the arterial wall. Circ Res 2004, 95:671-676.
8. Eghbali-Fatourechi G.Z., Lamsam J., Fraser D., et al. Circulating osteoblast-lineage cells in humans. N Engl J Med 2005, 352:1959-1966.
9. Chatterjee S., Bhunia A.K., Snowden A., Han H. Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiology 1997, 7:703-710.
10. Zalewski A., Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol 2005, 25:923-931.
11. Rosenson R.S., Gelb M.H. Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes. Curr Cardiol Rep 2009, 11:445-451.
12. Rosengren B., Jönsson-Rylander A.C., Peilot H., et al. Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis. Biochim Biophys Acta 2006, 1761:1301-1308.
13. Tokumura A., Sumida T., Toujima M., et al. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase. J Lipid Res 2000, 41:953-962.
14. Kougias P., Chai H., Lin P.H., et al. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 2006, 12:RA5-16.
15. Portman O.W., Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res 1969, 10:158-165.
16. Schmitz G., Ruebsaamen K. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 2010, 208:10-18.
17. Mannheim D., Herrmann J., Versari D., et al. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. Stroke 2008, 39:1448-1455.
18. Kohno M., Yokokawa K., Yasunari K., et al. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation 1998, 98:353-359.
19. Chen Y., Morimoto S., Kitano S., et al. Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 1995, 112:69-76.
20. Aiyar N., Disa J., Ao Z., et al. Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol Cell Biochem 2007, 295:113-120.
21. Yamakawa T., Eguchi S., Yamakawa Y., et al. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells. Hypertension 1998, 31:248-253.
22. Yamakawa T., Tanaka S., Yamakawa Y., et al. Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2002, 22:752-758.
23. Hu Y., Chan E., Wang S.X., Li B. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 2003, 144:2068-2074.
24. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 1995, 15:1858-1869.
25. Shioi A., Nishizawa Y., Jono S., et al. Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1995, 15:2003-2009.
26. Tanaka T., Sato H., Doi H., et al. Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells. Mol Cell Biol 2008, 28:1147-1160.
27. Jones D.C., Wein M.N., Oukka M., et al. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 2006, 312:1223-1227.
28. Inoue T., Kawashima H. 1,25-Dihydroxyvitamin D3 stimulates 45Ca2+-uptake by cultured vascular smooth muscle cells derived from rat aorta. Biochem Biophys Res Commun 1988, 152:1388-1394.
29. Jono S., Nishizawa Y., Shioi A., Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 1998, 98:1302-1306.
30. Proudfoot D., Davies J.D., Skepper J.N., et al. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 2002, 106:3044-3050.